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GENETIC DISORDERS – DEVELOPMENT
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fore birth, the mesangial cells in almost all glomeruli at theAn immunohistochemical study of developing glomeruli in hu-
late M stage acquire the adult phenotype.man fetal kidneys.
Background. In the glomerulonephritis, mesenchymal cells
frequently repeat the expression of fetal immunohistochemical
phenotypes. However, in human glomerulogenesis the pheno- The glomerulus, the most important filtering appara-typic alteration of mesangial and other types of glomerular
tus in the body, is a unique and highly specialized struc-cells has not been clearly defined. Our aim was to clarify the
ture. Three types of cells in the glomerular tufts, namelycharacteristics of fetal mesangial cells and glomerular capillary
endothelial cells, as well as their changes during glomerulogen- glomerular capillary endothelial cells, mesangial cells
esis using immunohistochemistry. and visceral glomerular epithelial cells, can be clearly
Methods. We examined the renal tissues of 34 autopsied identified, and their functions are now well understood.
fetuses and neonates, 5 children, and 5 adults using immunohis-
However, glomerulogenesis remains controversial. Fetaltochemistry and immunoelectron microscopy, using antibodies
glomerular features change so drastically during theirfor cytoskeletons, contraction-associated proteins, and endo-
thelial cell markers. development that it is very difficult to distinguish each
Results. In the V and S stages, there were no cells showing cell type in the developing glomeruli from routine histo-
mesangial and endothelial features within the vesicles and the logic and electron microscopic appearances alone.
S-shaped bodies. In the S stage, small blood vessels, consisting
In this study, we examined human fetal, neonatal, andof endothelial cells (CD311, CD341) and primitive perivascular
adult kidneys using immunohistochemistry and immuno-mesenchymal cells (a-smooth muscle actin1, low molecular
electron microscopy to distinguish each type of glomerularcaldesmon1, vimentin1), were branched from developing inter-
lobular arteries and appeared to extend to the lower clefts of cell. For glomerular capillary endothelial cells, we used
the S-shaped bodies. In the C stage, the perivascular mesenchy- CD31 [1, 2] and CD34 [3, 4]. Although no definite mark-
mal cells aggregated at the root of the immature glomeruli. In ers for mesangial cells have yet been found, a few studiesthe M stage, they migrated toward the periphery of immature
have reported that human and rat fetal mesangial cellsglomeruli and gradually lost their fetal immunohistochemical
are positive for a-smooth muscle actin (a-SMA) [5, 6],features. Similarly, with further maturation, the fetal glomeru-
lar capillary endothelial cells gradually lost the immunostaining compared with the negative immunostaining in adult
for CD34, while the strong staining intensity of CD31 remained mesangial cells. To study the phenotypic transformation
unchanged, just as that in the adult glomerular capillary endo- of mesangial cells and the relationship between normal
thelial cells. mesangial cells and glomerular capillary endothelial cellsConclusions. In human glomerulogenesis, we demonstrate
in development, we performed a double immunohisto-that fetal mesangial and capillary endothelial cells change their
chemical staining with both a-SMA and CD31 and im-immunohistochemical phenotypes with maturation. They grad-
ually lose fetal immunohistochemical phenotypes. Already be- munoelectron microscopy. An antibody against vimentin
was used to examine visceral glomerular epithelial cells
[7–10] and mesangial cells [8, 11, 12]. Furthermore, we
1 See Editorial by Oliver and Al-Awqati, p. 2167 compared the developing mesangial cells with other mes-
enchymal cells, such as vascular smooth muscle cells,Key words: immunohistochemistry, a-smooth muscle actin, vimentin,
smooth muscle myosin, caldesmon, CD31. pericytes, and stromal fibroblasts, using antibodies against
vimentin, smooth muscle myosin heavy chain (SM-MHC)Received for publication July 12, 1999
[13], calponin [14, 15], and caldesmon (CD) [15–17]. SM-and in revised form October 20, 1999
Accepted for publication December 5, 1999 MHC is a type of contractile protein that is expressed
in smooth muscle cells and myoepithelial cells [13]. Cal-Ó 2000 by the International Society of Nephrology
1836
Naruse et al: Immunohistochemistry of human fetal glomeruli 1837
Table 1. List of primary antibodies used for immunohistochemistry
Antibody Clone Dilution Specificity Source
Anti-human caldesmon h-CD 1:50 h-caldesmon (h-CD) DAKO, USA
Anti-human caldesmon TD107 1:50 caldesmon (CD) Novocastra, UK
Anti-human calponin CALP 1:50 calponin DAKO, USA
Anti-cytokeratin (AE1/AE3) AE1/AE3 1:400 56.5, 50, 509, 48, 40 kD of acidic Boehringer Mannheim, Germany
and all of basic cytokeratins
Anti-cytokeratin (CAM5.2) (CAM5.2) (2) cytokeratins less than 52 kD Becton Dickinson, USA
Anti-human endothelial cell JC/70A 1:20 CD31 DAKO, Denmark
Anti-human smooth muscle actin 1A4 1:50 a-smooth muscle actin (ASMA) DAKO, Denmark
Anti-human smooth muscle SMMS-1 1:50 smooth muscle myosin heavy DAKO, USA
myosin heavy chain chain (SM-MHC)
Anti-human progenitor cell MY10 1:20 CD34 Becton Dickinson, USA
antigen-1 (HPCA-1)
Anti-vimentin V9 1:25 vimentin DAKO, Denmark
Anti-laminin polyclonal 1:100 laminin BIO-SCIENCE PRODUCTS
AG, Switzerland
Anti-human type III collagen polyclonal 1:20 type III collagen MONOSAN, The Netherlands
Anti-human type IV collagen polyclonal 1:1000 type IV collagen LSL, Japan
Fig. 1. Immunohistochemical staining of human fetal glomeruli in the V stage. (a) a-Smooth muscle actin (a-SMA). (b) Caldesmon (CD). (c)
CD31 is expressed in endothelial cells of perivesicular capillaries. (d ) Vimentin is expressed in perivesicular and subcapsular mesenchymal cells
(bar 5 50 mm).
ponin is a type of contraction-associated protein (34 kD) h-CD (120 to 150 kD) and l-CD (70 to 80 kD) [15–18].
h-CD is predominantly expressed in mature smooth musclethat binds to calmodulin and F-actin and is only expressed
in well-developed smooth muscle cells [14, 15]. CD is also cells, whereas l-CD is primarily found in nonmuscle tissue
and cells [17, 18]. To our knowledge there have been noa contraction-associated protein and has two isoforms,
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Fig. 2. Immunohistochemical staining of human fetal glomeruli in the S stage. (a) a-SMA. (b) CD. (c) CD31-positive endothelial cells (double
arrows). (d ) Vimentin-positive mesenchymal cells (arrow) are seen in the lower cleft of the S-shaped body, in close association with CD31-positive
endothelial cells (bar 5 50 mm).
previous reports using SM-MHC, calponin and CD in fixed in 10% phosphate-buffered formalin and were em-
bedded in paraffin and cut into about 3 mm in thickness,the study of glomerular cells in human fetal kidneys.
We immunohistochemically examined the phenotypic according to conventional techniques. The kidney tissues
of 6 fetuses, from 13 to 38 weeks of gestation, were usedtransformation of each glomerular cell with maturation
in glomerulogenesis. for routine electron microscopy. Two of them, at 24 and
26 weeks of gestation, were also examined by immuno-Based on the characteristic light-microscopic appear-
ances of glomeruli, four developmental stages have been electron microscopy. None of the kidney tissues used in
this study showed macroscopical anomalies or micro-identified: the vesicle (V), the S-shaped body (S), the
capillary loop (C), and the maturing glomerulus (M) stages scopical abnormalities in the conventional staining prep-
arations, including hematoxylin and eosin, periodic acid[19, 20]. We have followed this classification in this study.
Schiff, Masson’s trichrome, and periodic acid methena-
mine silver impregnation.
METHODS
Renal tissues Immunohistochemistry
The deparaffinized and rehydrated sections of renalHuman renal tissues from 34 fetuses and 5 neonates,
5 children, and 5 adults were obtained from autopsied tissues were treated with 3% hydrogen peroxide, washed
with phosphate buffered saline (PBS), and then incubatedcases at the Kochi Medical School Hospital. Fetal ages
were estimated from the gestational age, ranging from with one of the primary antibodies (Table 1) and subse-
quently processed using the streptavidin-biotin-immuno-13 to 40 weeks (13 to 19 weeks, N 5 3; 20 to 25 weeks,
N 5 7; 26 to 30 weeks, N 5 9; 31 to 35 weeks, N 5 8; peroxidase method [SAB; Histofine SAB-PO(M) Kit;
Nichirei, Tokyo, Japan] with 3,39-diaminobenzidine tet-and 36 to 40 weeks, N 5 12). Child and adult cases
ranged from 1 to 35 years old. The kidney tissues were rachloride (DAB) as the chromogen. The sections were
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Fig. 3. Immunohistochemical staining of human fetal glomeruli in the C stage. (a) a-SMA. (b) CD are positive for aggregated mesenchymal cells
(arrow) at the root of immature glomeruli. (c) CD31 is positive along immature glomerular capillaries located under immature visceral glomerular
epithelial cells. (d ) The mesenchymal cells have lost vimentin expression with the aggregation, whereas immature visceral glomerular epithelial
cells become positive for vimentin (bar 5 50 mm).
briefly counterstained with hematoxylin and mounted specimen were vascular smooth muscle cells for a-SMA,
SM-MHC, h-CD and CD, and vascular endothelial cellswith Eukitt (Kindler, Freiburg, Germany). The sections
for anti-CD31, anti-CD34, anti-calponin, anti-cytokera- for CD31, CD34 and vimentin. For type IV collagen and
laminin, the positive internal control was a peritubulartins (AE1/AE3 and CAM 5.2), anti-laminin, and anti-
type III and IV collagens were pretreated before immu- basement membrane. Appropriate negative controls for
all antibodies were also performed.nostaining with 0.1% pronase E for 20 minutes at 378C.
The sections for anti–h-CD and anti-CD were micro-
Electron and immunoelectron microscopywaved for five minutes three times in 10 mmol/L citrate
buffer, pH 6.0. The sections of anti–SM-MHC were pre- For electron microscopy, the autopsied kidney tissues
were immediately fixed in 2.5% cacodylate-buffered glu-treated before immunostaining with 0.01% pronase K
for 10 minutes at room temperature, and the water bath taraldehyde and postfixed in 1% osmium tetroxide, de-
hydrated with a series of ascending alcohols and propyl-method was used in 10 mmol/L citrate buffer, pH 6.0,
as well as a water bath to 95 to 998C for 40 minutes. ene oxide, and then embedded in epoxy resin. Ultrathin
sections stained with uranyl acetate and lead citrate wereFurthermore, we performed a double immunostaining
for a-SMA and CD31. a-SMA was labeled with peroxi- examined with an electron microscope (JEM100S; JEOL
Ltd., Tokyo, Japan). For immunoelectron microscopy [21],dase-DAB, and CD31 was labeled with alkaline phospha-
tase-fast blue. CD has two types: high (h) and low (l) renal tissues were fixed for six hours by immersion in
periodate-lysine-paraformaldehyde solution. The mate-molecular CDs. Anti-CD reacts with total CD, and
anti–h-CD reacts only with a high molecular CD. Thus, rials were cut into about 50 mm in thickness on a tissue
sectioner (DTK-2000; DOSAKA EM Co., Ltd., Kyoto, Ja-we assumed that l-CD was positive when CD was positive
and h-CD was negative. Positive internal controls in each pan). The sections were then incubated with anti–a-SMA.
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Fig. 4. Immunohistochemical staining of human fetal glomeruli in the M stage. (a) a-SMA. (b) CD are positive for migrating mesenchymal cells,
namely mesangial cells. (c) CD31 is positive in endothelial cells of the glomerular capillaries. (d ) Vimentin is expressed only in visceral glomerular
epithelial cells (bar 5 50 mm).
Subsequent immunocytochemical procedures were per- (CD31, Fig. 1c). Vimentin was weakly positive in capsu-
lar and some perivesicular mesenchymal cells (vimentin,formed as described previously in this article, except for
the additional prefixation in 0.5% glutaraldehyde. Thin Fig. 1d). Type IV collagen and laminin were positive in
the perivesicular area. Cytokeratins (CAM 5.2 and AE1/fragments of sections were processed and embedded in
epoxy resin as stated previously in this article. The ultra- AE3) were negative in the vesicle (figures not shown).
The S stage. The vesicle was then gradually elongated,thin sections were stained with lead citrate and examined
with an electron microscope. twisted, and transformed via a comma-shaped body into
the S-shaped body with a narrow lumen (Fig. 2). The
epithelial cells of the S-shaped body were negative for
RESULTS
examined antibodies. Into the lower cleft of the S-shaped
Immunohistochemical study body, a small blood vessel of both CD311 and CD341
endothelial cells and circumferential mesenchymal cellsThe V stage. At the initial stage of glomerular devel-
opment, a cluster of primitive mesenchymal cells was positive for a-SMA, l-CD, and vimentin were seen
(a-SMA, Fig. 2a; CD, Fig. 2b; CD31, Fig. 2c; vimentin,formed in the nephrogenic zone, namely the outer corti-
cal portion beneath the capsule (Fig. 1). The mesenchy- Fig. 2d). Around the small blood vessel, type IV collagen
and laminin were positive. Cytokeratins were transientlymal cell cluster was called “the vesicle.” At 13 weeks,
vesicles already appeared in the nephrogenic zone. The positive in the upper and lower cell layers, especially on
their luminal surfaces (not shown).cells of the vesicles were negative for all examined anti-
bodies, while the perivesicular mesenchymal cells were The C stage. The differentiated lower limb of the
S-shaped body formed an immature glomerulus (Fig. 3).positive for a-SMA and l-CD (a-SMA, Fig. 1a; CD,
Fig. 1b). CD31 and CD34 were strongly positive in the Both the a-SMA1, l-CD1 mesenchymal cells and CD311,
CD341 endothelial cells of the blood vessel increased incapillary endothelial cells in the nephrogenic zone
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munostaining with the cell flattening. Among compo-
nents of the extracellular matrix examined, type IV colla-
gen and laminin were positive in developing glomeruli
but were always negative for type III collagen. Cytokera-
tins, which were expressed in the S-shaped body, disap-
peared in the C stage (not shown).
The M stage. The immature glomerulus became en-
larged and more numerous capillary loops constituted
complicated glomerular tufts (Fig. 4). In the early M
stage, the a-SMA1, l-CD1 mesenchymal cells at the root
of the immature glomerulus appeared to migrate to the
periphery with capillary development. Consequently, by
the late M stage, they were scattered in the developing
glomerulus (a-SMA, Fig. 4a; CD, Fig. 4b). Until this
stage, the immunostaining pattern of a-SMA was similar
to l-CD. However, with maturation, the glomerulus grad-
ually decreased their reactivity for a-SMA and l-CD. In
almost all glomeruli at the late M stage, the mesangial
cells became negative for a-SMA. All glomeruli in nor-
mal children and adults were negative for a-SMA,
whereas l-CD was still weakly positive. The CD31 immu-
nostaining pattern of glomerular capillary endothelial
cells in this stage appeared to be similar to that of adult
glomeruli (CD31, Fig. 4c). In the late M stage, CD34 on
glomerular capillary endothelial cells gradually disap-
peared. The CD34 immunostaining pattern was the same
in children’s kidneys, whereas it became very scarce or
negative in adult glomerular endothelial cells. The vis-
ceral glomerular epithelial cells were distributed at the
periphery of the glomerular tuft. They expressed vimen-
tin throughout the cytoplasm (vimentin, Fig. 4d), com-
pared with a preferential staining of the infranuclear
cytoplasm in the C stage. Even in child and adult glomer-
Fig. 5. Immunohistochemical staining of human fetal renal vasculature. uli, visceral glomerular epithelial cells were positive for
An interlobular artery in the center of the figure extends to the cortex
vimentin. The glomerular basement membrane and adja-and strongly expresses a-SMA. Immature arterioles branch from the
interlobular artery and connect with adjacent glomeruli in each develop- cent tissue space were positive for type IV collagen and
mental stage. Abbreviations are: S, an S-shaped body in the S stage; laminin. Cytokeratins were negative in the M stage and
C, a glomerulus in the C stage; M, glomeruli in the M stage; and FC,
adult glomeruli (not shown). Furthermore, h-CD, SM-fibrous capsule. a-SMA staining (bar 5 70 mm).
MHC, and calponin, which were markers for well-devel-
oped vascular smooth muscle cells, were negative in glo-
meruli throughout the fetal stages examined.
number and formed a mixed cell cluster at the root of Renal vasculature. In fetal kidneys, the immunoreac-
the immature glomerulus (a-SMA, Fig. 3a; CD, Fig. 3b). tivity of the smooth muscle cells in each arterial segment
Furthermore, CD311, CD341 endothelial cells formed was different. The immunoreactivities of arterial smooth
a few glomerular capillaries adjacent to the immature muscle cells were divided into two types: the arteriolar
visceral glomerular epithelial cells, which showed a co- smooth muscle cells were positive for a-SMA, vimentin,
lumnar shape (CD31, Fig. 3c). The intensity of both SM-MHC, and l-CD, whereas the smooth muscle cells
CD31 and CD34 immunostaining on glomerular endo- from the interlobular to larger arteries were positive for
thelial cells was almost the same. The mesenchymal cells calponin and h-CD, in addition to a-SMA, vimentin, and
lost the immunostaining for vimentin with the progres- SM-MHC.
sion of cell aggregation. In contrast, the upper cell layer In contrast, the pericytes around the peritubular capil-
of the lower limb became positive for vimentin, preferen- laries were positive for a-SMA, vimentin, and l-CD and
tially in the infranuclear cytoplasm (vimentin, Fig. 3d). negative for SM-MHC, h-CD, and calponin.
The lower cell layer of the lower limb was also initially Interlobular arteries branch from arcuate arteries and
enter the cortex. At each developmental stage the glo-positive for vimentin, but gradually lost its vimentin im-
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Fig. 6. Double immunohistochemical staining using both a-SMA and CD31 antibodies of human fetal glomeruli. (a) The V stage. a-SMA–positive
mesenchymal cells and CD31-positive endothelial cells are identified by brown and purple, respectively. The vesicle structure (V) contains no
brown or purple-colored cells. (b) The S stage. CD31-positive endothelial cells (purple) with a-SMA–positive mesenchymal cells (brown) are
located in the lower cleft of the S-shaped body. (c and d ) The C stage. (e) The early M stage. a-SMA-positive mesenchymal cells with CD31-
positive glomerular endothelial cells aggregate at the root of developing glomerulus and then migrate to the periphery of the glomerular tuft. (f )
The late M stage. a-SMA expression of the mesangial cells gradually disappeared with their maturation (bar 5 50 mm).
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Table 2. Immunohistochemical staining pattern in each stage of human glomerulogenesis
V stage S stage C stage M stage
Cytoskeletons
ASMA perivesicular mesen- mesenchymal cells in cell clusters at the root of MC (the immunostaining
chymal cells (1) lower cleft and inter- immature glomeruli (1) decreased and almost
lobular arteries (1) disappeared)
vesicles (2) SMC from arterioles to large arteries and pericytes of
peritubular capillaries (1)
Vimentin perivesicular mesen- mesenchymal cells in cell clusters at the root of glomerular VEP (1)
chymal cells (weakly lower cleft (weakly immature glomeruli
positive) positive) (gradually disappeared)
immature glomerular VEP (1)
vesicles (2) SMC from arterioles to larger arteries, perivascular stromal cells
and pericytes of peritubular capillaries (1)
Cytokeratin vesicles (2) luminal surface of upper immature glomeruli and Bowman’s capsules (2)
(AE1/AE3 and and lower cell layers
CAM5.2) (transiently positive)
SM-MHC vesicles, S-shaped bodies and immature glomeruli (2) SMC from arterioles to large
arteries (1)
Contraction-associated proteins
l-CD perivesicular mesen- perivascular mesenchymal cell clusters at the root of imma- MC (1), but the staining became
chymal cells (1) cells in lower cleft and ture glomeruli (1) weak
interlobular arteries (1)
vesicles (2) SMC of arterioles to larger arteries, stromal mesenchymal cells
and pericytes of peritubular capillaries (1)
h-CD and calponin vesicles, S-shaped bodies and immature glomeruli (2) SMC from interlobular arteries to
larger arteries (1)
Endothelial cell markers
CD31 and CD34 capillary EN in nephro- arteriolar EN in lower immature glomerular capillary glomerular En (1), but CD34
genic zone (1) cleft (1) EN (1) staining became weak
vesicles (2) EN from arterioles to larger arteries and of peritubular capillaries (1)
Extracellular matrix
Type III collagen vesicles and S-shaped bodies (2) periglomerular and peritubular space in medulla (1)
Type IV collagen perivesicular area (1) pericellular space in pericellular space of cell cluster pericellular space of MC and
and laminin lower cleft (1) at the root of glomeruli and GBM (1)
GBM (1)
vesicles (2) periglomerular and peritubular basement membrane (1)
Symbols and abbreviations are: (1) positive; (2) negative; CD, low (l) and high (h) caldesmon; EN, endothelial cells; GBM, glomerular basement membrane;
MC, mesangial cells; SMC, smooth muscle cells; VEP, visceral epithelial cells.
meruli, from subcapsular immature glomeruli to jux- (Fig. 6b). Both types of cells of the arteriole aggregated
at the root of the immature glomerulus in the early Ctamedullary more developed glomeruli, were located ad-
jacent to the interlobular arteries. Arterioles branching stage. Subsequently, CD311 endothelial cells were sepa-
rated from the cluster and formed glomerular capillariesfrom the interlobular arteries appeared to connect devel-
oping glomeruli (Fig. 5). between the a-SMA1 mesenchymal cell cluster and vis-
ceral glomerular epithelial cells (Fig. 6c). In the late C
Immunohistochemical study: Double staining with stage, a-SMA1 mesenchymal cells appeared to migrate
anti–a-smooth muscle actin and anti-CD31 antibodies toward the periphery of the immature glomerulus, asso-
ciated with CD311 glomerular capillary endothelial cellsIn the V stage, a-SMA1 mesenchymal cells were dis-
tributed around CD311 capillary endothelial cells in the (Fig. 6d). In the early M stage, a-SMA1 mesenchymal
cells were scattered and exclusively located in the mesan-perivesicular area of the nephrogenic zone, while the
cells of the vesicle were negative to both a-SMA and gium (Fig. 6e). Subsequently, in the late M stage a-SMA
staining of mesangial cells disappeared, whereas theCD31 staining (Fig. 6a). The arteriole of CD311 endo-
thelial cells and a-SMA1 circumferential mesenchymal CD31 immunostaining of glomerular capillary endothe-
lial cells remained (Fig. 6f).cells was seen in the lower cleft of the S-shaped body
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Fig. 7. Immunoelectron micrographs of hu-
man fetal glomeruli in the S and C stages. (a)
The a-SMA–positive mesenchymal cells and
the a-SMA–negative endothelial cells are seen
side by side in the lower cleft. (b) a-SMA–
positive mesenchymal cells aggregated at the
root of the glomerulus and a-SMA–negative
endothelial cells are located adjacent to the
visceral glomerular epithelial cells. Abbrevia-
tions are: Me, immature mesangial cells; En,
immature glomerular capillary endothelial
cells; Ep, immature visceral glomerular epi-
thelial cells; ML, middle limb; LL, lower limb;
Slc, remaining space of lower cleft (bar 5
10 mm).
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The results of immunostaining for antibodies used in neys. These cells were differentiated by a gradual loss
of their fetal phenotypes: a-SMA1, l-CD1, vimentin1this study are summarized in Table 2.
for mesangial cells, and CD341 for glomerular capillary
Electron and immunoelectron microscopy endothelial cells.
Although it has been shown that human and rat fetalPerivascular mesenchymal cells and endothelial cells
were examined by electron microscope during the S and mesangial cells express a-SMA [5, 6], we demonstrated
that human fetal mesangial cells change a-SMA expres-C stages. However, it was difficult to clearly distinguish
between developing endothelial cells and perivascular sion in the course of glomerular development. The pro-
genitor and immature mesangial cells are initially posi-mesenchymal cells by routine electron microscopy alone.
By immunoelectron microscopy, in the early S stage, tive for a-SMA in the S and C stages and then become
a-SMA2 endothelial cells were located in the lower cleft, a-SMA negative from the late M stage. Meanwhile, vi-
side by side with a-SMA1 mesenchymal cells (Fig. 7a). mentin is expressed in the adult visceral glomerular epi-
The a-SMA1 mesenchymal cells had very elongated cell thelial cells [7–9], but descriptions of the vimentin ex-
processes compared with endothelial cells. There was a pression in the mesangial cells vary [7–9]. It is possible
loose extracellular matrix around the a-SMA1 mesen- that the different results of previous immunohistochemi-
chymal cell processes. cal studies may depend on the methods and antibodies
In the C stage, a-SMA1 mesenchymal cells and used [10]. In most of the previous articles on glomerular
a-SMA2 endothelial cells aggregated at the root of the development, vimentin was positive only in the glomeru-
immature glomeruli and increased in number (Fig. 7b). lar visceral epithelial cells of human fetal kidneys, but
a-SMA1 mesenchymal cells had irregularly extended negative in the developing mesangial cells [7, 9, 10]. How-
cell processes. There was a loose attachment between ever, according to Holtho¨fer et al vimentin was expressed
the a-SMA1 mesenchymal cells and endothelial cells. by the mesenchymal cells in the clefts of the S-shaped
These ultrastructural findings confirmed the pre- bodies and was slightly expressed by the glomerular cap-
viously described immunohistochemical staining pattern illary endothelial cells and developing mesangial cells
for a-SMA. [7]. Holtho¨fer et al’s results are virtually the same as
those of our studies.
In human and experimental glomerulonephritis andDISCUSSION
also culture conditions, activated mesangial cells express
We immunohistochemically examined the developing a-SMA [22–27], l-CD [25], and vimentin [11, 12]. These
human fetal glomeruli in order to clarify the phenotypic features of activated mesangial cells in adult diseased
transformation of each glomerular cell with glomerulo- glomeruli may reflect the repetition of phenotypic mark-
genesis. ers of fetal mesangial cells.
In the V stage, the cells of the primitive glomerular In conclusion, using immunohistochemistry and im-
anlages were immunohistochemically negative for cyto- munoelectron microscopic techniques, we demonstrate
skeletons, contraction-associated proteins, and markers that fetal mesangial and glomerular capillary endothelial
for capillary endothelial cells examined in this study. cells gradually lose their fetal immunohistochemical phe-
With the progression to the S stage, small blood vessels notypes. Mesangial cells in almost all glomeruli at the
composed of endothelial cells (CD311 and CD341) and late M stage have already acquired the adult phenotype
circumferential mesenchymal cells (a-SMA1, l-CD1, in human glomerulogenesis.
and vimentin1) branched from the immature interlobu-
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